Cargando…
A fully human connective tissue growth factor blocking monoclonal antibody ameliorates experimental rheumatoid arthritis through inhibiting angiogenesis
BACKGROUND: Connective tissue growth factor (CTGF) plays a pivotal role in the pathogenesis of rheumatoid arthritis (RA) by facilitating angiogenesis and is a promising therapeutic target for RA treatment. Herein, we generated a fully human CTGF blocking monoclonal antibody (mAb) through phage displ...
Autores principales: | Qin, Yang, Wu, Gan, Jin, Jiayi, Wang, Hao, Zhang, Jiani, Liu, Li, Zhao, Heping, Wang, Jianguang, Yang, Xinyu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9985226/ https://www.ncbi.nlm.nih.gov/pubmed/36869335 http://dx.doi.org/10.1186/s12896-023-00776-8 |
Ejemplares similares
-
KIAA1199 as a potential diagnostic biomarker of rheumatoid arthritis related to angiogenesis
por: Yang, Xinyu, et al.
Publicado: (2015) -
Connective tissue growth factor-targeting DNA aptamer suppresses pannus formation as diagnostics and therapeutics for rheumatoid arthritis
por: Wu, Gan, et al.
Publicado: (2022) -
Serum connective tissue growth factor is a highly discriminatory biomarker for the diagnosis of rheumatoid arthritis
por: Yang, Xinyu, et al.
Publicado: (2017) -
Angiogenesis in rheumatoid arthritis
por: Paleolog, Ewa M
Publicado: (2002) -
Secreted KIAA1199 promotes the progression of rheumatoid arthritis by mediating hyaluronic acid degradation in an ANXA1-dependent manner
por: Zhang, Wei, et al.
Publicado: (2021)